ResearcherUniversidad de MurciaActive in the last 2 years
Alberto Carmona‐Bayonas
Matched on ORCID iD 0000-0002-1930-9660; OpenAlex author ID A5025609786. Sources: OpenAlex.
Their work
- Papers
- 6 (first author 0, last author 2)
- Trials
- 0
- Grants
- 0
- Labs led
- 1
- Collaborators
- 24
2017: 2 papers · 2018: 1 paper · 2019: none · 2020: none · 2021: none · 2022: none · 2023: none · 2024: 1 paper · 2025: none · 2026: 2 papers
Papers 6
- Prognostic modeling of overall survival in metastatic pancreatic cancer: an inflammation-based tool validated in PANTHEIA-SEOM cohort. Last author DOI 10.1007/s12094-026-04554-8↗
- Systemic inflammation response index (SIRI) predicts outcomes and chemotherapy benefit in metastatic pancreatic cancer: A study by the PANTHEIA- SEOM group. Co-author DOI 10.1016/j.pan.2026.08.008↗
- Systemic Inflammation Response Index and weight loss as prognostic factors in metastatic pancreatic cancer: A concept study from the PANTHEIA-SEOM trial. Co-author DOI 10.4251/wjgo.v16.i2.386↗
- Prognostic factors for survival with nab-paclitaxel plus gemcitabine in metastatic pancreatic cancer in real-life practice: the ANICE-PaC study. Last author DOI 10.1186/s12885-018-5101-3↗
- Consensus guidelines for diagnosis, treatment and follow-up of patients with pancreatic cancer in Spain. Co-author DOI 10.1007/s12094-016-1594-x↗
- Supportive care in pancreatic ductal adenocarcinoma. Co-author DOI 10.1007/s12094-017-1682-6↗
Closest collaborators
The 24 strongest of 24 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Javier Gallego-Plazas · 5 shared papers, 2017–2026 · strength 0.76
- Paper Prognostic modeling of overall survival in metastatic pancreatic cancer: an inflammation-based tool validated in PANTHE… DOI 10.1007/s12094-026-04554-8↗
- Paper Systemic inflammation response index (SIRI) predicts outcomes and chemotherapy benefit in metastatic pancreatic cancer:… DOI 10.1016/j.pan.2026.08.008↗
- Paper Systemic Inflammation Response Index and weight loss as prognostic factors in metastatic pancreatic cancer: A concept s… DOI 10.4251/wjgo.v16.i2.386↗
- Vilma Pacheco-Barcía · 3 shared papers, 2024–2026 · strength 0.66
- Paper Prognostic modeling of overall survival in metastatic pancreatic cancer: an inflammation-based tool validated in PANTHE… DOI 10.1007/s12094-026-04554-8↗
- Paper Systemic inflammation response index (SIRI) predicts outcomes and chemotherapy benefit in metastatic pancreatic cancer:… DOI 10.1016/j.pan.2026.08.008↗
- Paper Systemic Inflammation Response Index and weight loss as prognostic factors in metastatic pancreatic cancer: A concept s… DOI 10.4251/wjgo.v16.i2.386↗
- Carmen Guillén‐Ponce · 4 shared papers, 2017–2026 · strength 0.55
- Paper Prognostic modeling of overall survival in metastatic pancreatic cancer: an inflammation-based tool validated in PANTHE… DOI 10.1007/s12094-026-04554-8↗
- Paper Systemic inflammation response index (SIRI) predicts outcomes and chemotherapy benefit in metastatic pancreatic cancer:… DOI 10.1016/j.pan.2026.08.008↗
- Paper Prognostic factors for survival with nab-paclitaxel plus gemcitabine in metastatic pancreatic cancer in real-life pract… DOI 10.1186/s12885-018-5101-3↗
- Andrés Jesús Muñoz Martín · 3 shared papers, 2018–2026 · strength 0.49
- Paper Systemic inflammation response index (SIRI) predicts outcomes and chemotherapy benefit in metastatic pancreatic cancer:… DOI 10.1016/j.pan.2026.08.008↗
- Paper Systemic Inflammation Response Index and weight loss as prognostic factors in metastatic pancreatic cancer: A concept s… DOI 10.4251/wjgo.v16.i2.386↗
- Paper Prognostic factors for survival with nab-paclitaxel plus gemcitabine in metastatic pancreatic cancer in real-life pract… DOI 10.1186/s12885-018-5101-3↗
- Ángela Lamarca · 2 shared papers, 2026 · strength 0.45
- Paper Prognostic modeling of overall survival in metastatic pancreatic cancer: an inflammation-based tool validated in PANTHE… DOI 10.1007/s12094-026-04554-8↗
- Paper Systemic inflammation response index (SIRI) predicts outcomes and chemotherapy benefit in metastatic pancreatic cancer:… DOI 10.1016/j.pan.2026.08.008↗
- Elena Brozos-Vázquez · 2 shared papers, 2026 · strength 0.45
- Paper Prognostic modeling of overall survival in metastatic pancreatic cancer: an inflammation-based tool validated in PANTHE… DOI 10.1007/s12094-026-04554-8↗
- Paper Systemic inflammation response index (SIRI) predicts outcomes and chemotherapy benefit in metastatic pancreatic cancer:… DOI 10.1016/j.pan.2026.08.008↗
- Luis Cabezón‐Gutiérrez · 2 shared papers, 2024–2026 · strength 0.43
- Paper Systemic inflammation response index (SIRI) predicts outcomes and chemotherapy benefit in metastatic pancreatic cancer:… DOI 10.1016/j.pan.2026.08.008↗
- Paper Systemic Inflammation Response Index and weight loss as prognostic factors in metastatic pancreatic cancer: A concept s… DOI 10.4251/wjgo.v16.i2.386↗
- Ismael Ghanem · 1 shared paper, 2026 · strength 0.23
- Berta Laquente · 2 shared papers, 2017 · strength 0.13
- Alfredo Carrato · 2 shared papers, 2017 · strength 0.13
- Mercedes Salgado · 2 shared papers, 2017–2018 · strength 0.10
- Roberto Pazo-Cid · 2 shared papers, 2017–2018 · strength 0.10
- Adelaida Garcia-Velasco · 1 shared paper, 2018 · strength 0.06
- Ruth Vera · 1 shared paper, 2018 · strength 0.06
- Ana Fernández · 1 shared paper, 2018 · strength 0.06
- Carlos Plaza · 1 shared paper, 2017 · strength 0.04
- Antonio Gámez Martínez · 1 shared paper, 2017 · strength 0.04
- Enrique de‐Madaria · 1 shared paper, 2017 · strength 0.04
- Rafael Álvarez-Gallego · 1 shared paper, 2017 · strength 0.04
- Joaquina Martínez-Galán · 1 shared paper, 2017 · strength 0.04
- Ruth Vera · 1 shared paper, 2017 · strength 0.04
- P. Jiménez · 1 shared paper, 2017 · strength 0.04
- Manuel M. Hidalgo · 1 shared paper, 2017 · strength 0.04
- Teresa Mercade Macarulla · 1 shared paper, 2017 · strength 0.04
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.